drugset / Trial / NCT00178503
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
Phase 2/3
Completed
24 enrolled
The University of Texas Health Science Center, Houston
National Institute of Mental Health (NIMH) · collab
RandomizedSingle-groupQuadruple-blindTreatment
Summary
This study examined the cognitive and behavioral differences in children who have an autism spectrum disorder (ASD) with or without additional symptoms of ADHD. The study also examined the effectiveness of a range of doses of methylphenidate in improving cognitive and behavioral outcomes in children with both ASD and ADHD.
Timeline
- Start
- 2005-09
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | 2.5 mg | — |
| Comparator | Methylphenidate | Small molecule | 5 mg | — |
| Comparator | Methylphenidate | Small molecule | 10 mg | — |
| Comparator | Methylphenidate | Small molecule | 20 mg | — |
| Comparator | Methylphenidate | Small molecule | 30 mg | — |
| Comparator | Methylphenidate | Small molecule | 40 mg | — |